PEGylated TiO 2 nanoparticles mediated inhibition of cell migration via integrin beta 1
Source abstract
Abstract
Nanoparticles (NPs) elicit various physiological responses in cellular environment, and the effect of NPs on cell migration is of high interest. In this work, the effects of NPs on cell migration and their possible mechanisms were studied. Here, we showed that after exposure to pegylated titanium dioxide nanoparticles (TiO2-PEG NPs, where PEG stands for the polyethylene glycol), NCI-H292 cells exhibited slower migration than control cells. Furthermore, larger NPs inhibited cell migration much stronger than smaller NPs. Following NP exposure, the cells showed decreased expression of integrin beta 1 and phosphorylated focal adhesion kinase (pFAK), and disrupted F-actin structures. We demonstrated that a possible mechanism involved NP-mediated promotion of the lysosomal degradation of integrin beta 1, thus leading to reduced expression of pFAK and cytoskeletal disruption and inhibited cell migration. Therefore, our results showed that inhibition of NCI-H292 cell migration by NPs is mediated through integrin beta 1, which provides useful information for the application of NPs in cancer therapy and related fields.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
,
Funding
National Institute for Materials Science
References (55)
Show source-provided references
1. 10.1038/nrc156610.1038/nrc1566 ↗
2. 10.1039/C4CS00362D10.1039/C4CS00362D ↗
3. 10.1016/j.tifs.2016.06.00810.1016/j.tifs.2016.06.008 ↗
4. 10.1021/acs.accounts.5b0003810.1021/acs.accounts.5b00038 ↗
5. 10.1007/s11051-013-1692-410.1007/s11051-013-1692-4 ↗
6. 10.1088/1742-6596/617/1/01203210.1088/1742-6596/617/1/012032 ↗
7. Cha K-E , Myung H . Cytotoxic effects of nanoparticles assessed in vitro and in vivo . J Microbiol Biotechnol. 2007;17:1573–1578.
8. Bahadar H , Maqbool F , Niaz K , et al . Toxicity of nanoparticles and an overview of current experimental models. Iran Biomed J. 2016;20:1–11.
9. 10.1002/smll.v6:2010.1002/smll.v6:20 ↗
10. 10.1016/j.biomaterials.2009.04.00910.1016/j.biomaterials.2009.04.009 ↗
11. 10.1016/j.jfda.2014.01.00510.1016/j.jfda.2014.01.005 ↗
12. 10.1021/ja910269810.1021/ja9102698 ↗
13. 10.3389/fncel.2015.0038110.3389/fncel.2015.00381 ↗
14. 10.1126/science.109205310.1126/science.1092053 ↗
15. 10.1016/S0092-8674(00)81280-510.1016/S0092-8674(00)81280-5 ↗
16. 10.1016/j.cell.2006.01.00710.1016/j.cell.2006.01.007 ↗
17. 10.1155/2000/7904510.1155/2000/79045 ↗
18. 10.1038/nnano.2016.7210.1038/nnano.2016.72 ↗
19. 10.1021/nn507025910.1021/nn5070259 ↗
20. 10.1016/j.biomaterials.2017.11.02510.1016/j.biomaterials.2017.11.025 ↗
21. 10.1371/journal.pone.009917510.1371/journal.pone.0099175 ↗
22. 10.1002/smll.v5:410.1002/smll.v5:4 ↗
23. 10.1038/ncb0402-e6510.1038/ncb0402-e65 ↗
24. Akiyama SK . Integrins in cell adhesion and signaling. Hum Cell. 1996;9:181–186.
25. 10.1242/jcs.114.5.94110.1242/jcs.114.5.941 ↗
26. 10.1016/j.devcel.2008.12.00710.1016/j.devcel.2008.12.007 ↗
27. 10.1242/jcs.09581010.1242/jcs.095810 ↗
28. 10.1021/es204168d10.1021/es204168d ↗
29. 10.1039/c3cp43938 k10.1039/c3cp43938 k ↗
30. 10.1007/s11569-010-0090-y10.1007/s11569-010-0090-y ↗
31. 10.1039/C6BM00946H10.1039/C6BM00946H ↗
32. 10.1080/14686996.2016.123949910.1080/14686996.2016.1239499 ↗
33. 10.1038/nprot.2007.3010.1038/nprot.2007.30 ↗
34. 10.1021/nl403254910.1021/nl4032549 ↗
35. 10.1016/j.colsurfb.2009.04.02510.1016/j.colsurfb.2009.04.025 ↗
36. 10.1002/smll.20080064610.1002/smll.200800646 ↗
37. 10.2147/NSA.S2551510.2147/NSA.S25515 ↗
38. 10.1021/acsnano.6b0834510.1021/acsnano.6b08345 ↗
39. 10.5772/intechopen.6937010.5772/intechopen.69370 ↗
40. 10.1002/(ISSN)1097-018510.1002/(ISSN)1097-0185 ↗
41. 10.1074/jbc.M60669520010.1074/jbc.M606695200 ↗
42. 10.1152/physrev.00021.200710.1152/physrev.00021.2007 ↗
43. 10.4161/spmg.2538510.4161/spmg.25385 ↗
44. 10.4161/tisb.2425210.4161/tisb.24252 ↗
45. 10.1242/jcs.16165310.1242/jcs.161653 ↗
46. 10.1016/j.ceb.2011.08.00510.1016/j.ceb.2011.08.005 ↗
47. 10.1038/nrm275510.1038/nrm2755 ↗
48. 10.2147/IJN.S2659210.2147/IJN.S26592 ↗
49. 10.1074/jbc.M111.26082810.1074/jbc.M111.260828 ↗
50. 10.1016/j.devcel.2011.11.00810.1016/j.devcel.2011.11.008 ↗
51. 10.1038/3501051710.1038/35010517 ↗
52. 10.1083/jcb.146.2.38910.1083/jcb.146.2.389 ↗
53. 10.1128/MCB.19.7.480610.1128/MCB.19.7.4806 ↗
54. 10.1242/jcs.112.16.267710.1242/jcs.112.16.2677 ↗
55. 10.1242/bio.01755810.1242/bio.017558 ↗